BRIDGEWATER, N.J., Dec. 8, 2017 /PRNewswire/ — Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration (“FDA”) approval on its Abbreviated New Drug Application (“ANDA”) for a generic…
